Actually, everything you just you wrote (copied) proves I am right. Thanks. PS is not just present on tumor cells but gets exposed on apoptotic cells throughout the body. That extra PS acts as a sink to draw away anti-PS antibodies. It couldn't be more clearer than that.
Quote:it explains why Bavi likely isn't a good anti-cancer target
But hey, I give you the word LIKELY. And by the way I we need a clinical trial to prove Bavi works with IO then you need one to prove it doesn't work with IO. And since there isn't any public data...at my knowledge.
As a scientist, I try not to use absolutes even in cases where data suggests little chance for success, like in the case of Bavi so I used "likely ins't a good target". More importantly, there is no data from ANY clinical trials showing Bavi it has any efficacy as a single agent. That is a major strike against it.